- Home
- OPAD vs KALA Comparison
OPAD vs KALA Comparison
Compare OPAD & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- KALA
- Stock Information
- Founded
- OPAD 2015
- KALA 2009
- Country
- OPAD United States
- KALA United States
- Employees
- OPAD N/A
- KALA N/A
- Industry
- OPAD Real Estate
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- OPAD Finance
- KALA Health Care
- Exchange
- OPAD Nasdaq
- KALA Nasdaq
- Market Cap
- OPAD 25.3M
- KALA 26.2M
- IPO Year
- OPAD N/A
- KALA 2017
- Fundamental
- Price
- OPAD $1.38
- KALA $5.87
- Analyst Decision
- OPAD Hold
- KALA Strong Buy
- Analyst Count
- OPAD 5
- KALA 3
- Target Price
- OPAD $2.38
- KALA $14.00
- AVG Volume (30 Days)
- OPAD 144.5K
- KALA 125.3K
- Earning Date
- OPAD 08-04-2025
- KALA 08-05-2025
- Dividend Yield
- OPAD N/A
- KALA N/A
- EPS Growth
- OPAD N/A
- KALA N/A
- EPS
- OPAD N/A
- KALA N/A
- Revenue
- OPAD $794,159,000.00
- KALA N/A
- Revenue This Year
- OPAD N/A
- KALA N/A
- Revenue Next Year
- OPAD $40.79
- KALA N/A
- P/E Ratio
- OPAD N/A
- KALA N/A
- Revenue Growth
- OPAD N/A
- KALA N/A
- 52 Week Low
- OPAD $0.91
- KALA $2.92
- 52 Week High
- OPAD $5.13
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- OPAD 70.23
- KALA 60.68
- Support Level
- OPAD $0.91
- KALA $4.36
- Resistance Level
- OPAD $1.59
- KALA $7.00
- Average True Range (ATR)
- OPAD 0.13
- KALA 0.71
- MACD
- OPAD 0.06
- KALA 0.16
- Stochastic Oscillator
- OPAD 77.94
- KALA 63.97
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.